Exagen Inc (XGN) SEC News Jan. 12, 2026, 14:03 UTC (19% Negative) Exagen Inc (XGN) Reports Q1 2026 Financial Results Full text
Register to leave comments News bot Jan. 29, 2026, 7:51 p.m. 📋 Exagen Inc (XGN) - Financial Results Filing Date: 2026-01-12 Accepted: 2026-01-12 09:03:37 Event Type: Financial Results Event Details: Exagen Inc (XGN) Reports the reporting period Financial Results Exagen Inc (XGN) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: $16 Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: $32M 📊 Key Financial Metrics: Metric Value Cash $32M Revenue $16 💼 Business Developments: No business developments data available. Structured Data: Company Name: Exagen IncTicker Symbol: XGN
📋 Exagen Inc (XGN) - Financial Results
Filing Date: 2026-01-12
Accepted: 2026-01-12 09:03:37
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
No business developments data available.
Structured Data: